WebNews
Please enter a web search for web results.
NewsWeb
A lung pathogen's dilemma: Infect or resist antibiotics?
7+ hour, 30+ min ago (412+ words) To survive tough conditions, P. aeruginosa forms colonies known as "biofilms" -- clusters of bacteria encased in a self-produced matrix that provides them with significant advantages, including protection from antibiotics. Mimicking natural infection environments to observe the bacteria To better understand P. aeruginosa's…...
Intellia's Data Reveal Tees Up FDA Filing for CRISPR-Based In Vivo Gene-Editing Med
4+ week, 1+ day ago (247+ words) Intellia Therapeutics" lonvo-z uses CRISPR to inactivate a gene in the liver to reduce levels of a protein key to the swelling attacks from the rare disease hereditary angioedema. Intellia has filed a regulatory submission for this genetic medicine, which…...
Intellia Therapeutics says its Crispr-based treatment succeeds in pivotal trial
1+ mon, 2+ hour ago (449+ words) Intellia Therapeutics said its Crispr-based treatment for a rare swelling condition met its goals in a late-stage trial, marking a milestone for the field of gene editing and putting the company on track to seek approval from the U. S. Food and…...
One-dose gene therapy shows up to 62% cut in bad cholesterol in early trial
7+ hour, 13+ min ago (493+ words) A Phase 1b clinical trial of Eli Lilly's gene therapy VERVE-102 has shown up to 62% reduction in LDL cholesterol with a single dose, raising hopes for long-term treatment of hypercholesterolaemia and heart disease risk. A one-time gene therapy for treating hypercholesterolaemia…...
Gene-editing cholesterol away, new Alzheimer's findings and a supplement warning
1+ day, 2+ hour ago (383+ words) A single infusion. A dramatic drop in bad cholesterol. And results that may last a lifetime. An experimental gene-editing treatment is turning heads in the medical world " and researchers say it could one day change the way heart'disease is prevented…...
Southeast Asian Hospital Teams Strengthen Efforts to Combat Antimicrobial Resistance
5+ hour, 1+ min ago (251+ words) Southeast Asia is among the global regions with the highest CRO burden. In 2021, between 8, 300 to 21, 800 deaths in the region were attributable to CROs. [[1]] To help address this challenge, CDC hosted a regional workshop in Bangkok, Thailand in December 2024 to improve…...
Al-Ola A Abdallah Comments On the New Article on Dual-Target CAR-T Strikes Hard in EMD - Onco Daily
18+ hour, 33+ min ago (269+ words) Al-Ola A Abdallah, Associate Professor and Plasma Cell Disorder Program Director of the Division of HMCT at the University of Kansas Medical Center, shared a post on'X: "Dual-Target CAR-T Strikes Hard in EMD: ORR 97%, PFS 6 months! Is Persistence the Missing…...
Breeze Bio Announces Scientific Advisory Board to Support Next Stage of Precision Genetic Medicine Pipeline Development
1+ day, 2+ hour ago (523+ words) Bio Space Breeze Bio Announces Scientific Advisory Board to Support Next Stage of Precision Genetic Medicine Pipeline Development SOUTH SAN FRANCISCO, Calif. --(BUSINESS WIRE)--#Nano Galaxy--Breeze Bio, Inc. , formerly known as Gen Edit, today announced the formation of its…...
One-time gene editing cuts LDL cholesterol in early hypercholesterolemia trial
18+ hour, 21+ min ago (483+ words) A single infusion of VERVE-102 sharply lowered PCSK9 and LDL cholesterol in a small phase 1 trial, offering early evidence for a potentially durable genetic approach to cholesterol control, while long-term safety and clinical benefit remain to be proven. Study: In Vivo…...
Eli Lilly Gene Therapy Cuts Cholesterol Dramatically in Early Trial
14+ hour, 33+ min ago (63+ words) Whalesbook Eli Lilly's gene-editing therapy VERVE-102 has shown impressive early results, cutting LDL-C by 62% and PCSK9 protein by 88% in a Phase 1b trial. This one-time treatment, acquired from Verve Therapeutics, aims to offer a permanent solution for high cholesterol patients, reducing the…...